Valicare business areas
As a subsidiary of Syntegon, Valicare offers GMP consulting and qualified validation services for pharmaceutical and biotechnological industries, including specialized support for cell and gene therapy.
As a subsidiary of Syntegon, Valicare offers GMP consulting and qualified validation services for pharmaceutical and biotechnological industries, including specialized support for cell and gene therapy.
As a subsidiary of Syntegon, Valicare shares the core competencies of the mother company with full access to technical know-how of all production sites. Syntegon is a leading provider of processing and packaging technology for the pharmaceutical industry and designs and manufactures pharmaceutical or active ingredient production equipment independently and self-sufficiently. The same accounts for Valicare's consultants and engineers with their variable teams that offer comprehensive qualification and validation support from a single source.
Cell and gene therapies are revolutionary innovations in medical treatment. The market for these novel therapeutics is increasing rapidly. They are defined through the guideline 2003/63/EG and comprise gene therapy, somatic cell therapy, and tissue engineering.
The use of biotechnological procedures in drug manufacturing is highly diverse. Valicare specialists have laid the foundations for a GMP-compliant process development in a multitude of exciting new biological and biotechnological customer processes.
Professional GMP compliance ensures the quality of drugs and active ingredients.
ATMPs offer new, promising therapeutic approaches for diseases that were previously considered incurable. However, the regulatory requirements are challenging.
Valicare is an ISO 9001-certified service company and operates in the area of qualification and validation of technical equipment and processes.